Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddys Laboratories informs about press release
Date: 27-03-2019Dr. Reddys Laboratories has informed that it has enclosed a Press Release on ' Dr. Rcddy's Laboratories launches Tadalafil Tablets USP in the US Market.'
The above information is a part of company’s filings submitted to BSE.